Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Biomark Capital

Founders David Wetherell

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 10
Rounds per year 1.56
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits 7
Key employees 5

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Pharmaceutical
Summary

Biomark Capital appeared to be the VC, which was created in 2013. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Biomark Capital, startups are often financed by Versant Ventures, Gund Investment, LLC, Greenwich Venture Capital Advisors. The meaningful sponsors for the fund in investment in the same round are Burrill & Company, Uncork Capital, Milestone Capital China. In the next rounds fund is usually obtained by Milestone Capital China, Kleiner Perkins, Hercules Capital, Inc..

Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2012. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2018. Opposing the other organizations, this Biomark Capital works on 35 percentage points more the average amount of lead investments.

We also calculated 5 valuable employees in our database.

The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Search Engine, Health Diagnostics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline MabVax Therapeutics, ADMA Biologics, WaveTec Vision For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Biomark Capital:
Typical Co-investors
Biomark Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Biomark Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ANU Connect Ventures Australia, Australian Capital Territory, Canberra
Apex Capital New York, New York, United States
Aslanoba Capital Istanbul, Istanbul, Turkey
Bank El Etihad Amman, Amman, Jordan
Chegg California, Santa Clara, United States
FarSight Ventures Andover, Massachusetts, United States
Genscape Kentucky, Louisville, United States
Incite Ventures Boise, Idaho, United States
iVenturers England, London, United Kingdom
JPMorgan Partners (JPMP) New York, New York, United States
On Ventures Distrito Federal, Mexico, Mexico City
Patriot Capital Baltimore, Maryland, United States
Prana Studios California, Los Angeles, United States
Qingda Chuangye Touzi China, Dongguang, Guangdong
Startupbootcamp Amsterdam Amsterdam, Noord-Holland, The Netherlands
The FinLab Central, Central Region, Singapore
The Wells Investment -
Tongcheng Zhongchuang Fund China, Jiangsu, Suzhou
TTC Ventures -
University of Michigan MINTS fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

JHL Biotech

Biotechnology
Health Diagnostics
Pharmaceutical
$35M19 Jun 2014 Hsinchu, Taiwan Province, Taiwan

BetterDoctor

Apps
Database
Developer APIs
Health Care
Internet
Medical
Mobile
Search Engine
$2M22 Oct 2013 San Francisco, California, United States

JHL Biotech

Biotechnology
Health Diagnostics
Pharmaceutical
17 Dec 2012 Hsinchu, Taiwan Province, Taiwan

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Biomark Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 13M
Rounds per year 1.56
Peak activity year 2012
Lead investments 0
Follow on index 0.29
Exits 7
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

JHL Biotech

Biotechnology
Health Diagnostics
Pharmaceutical
$35M19 Jun 2014 Hsinchu, Taiwan Province, Taiwan

BetterDoctor

Apps
Database
Developer APIs
Health Care
Internet
Medical
Mobile
Search Engine
$2M22 Oct 2013 San Francisco, California, United States

JHL Biotech

Biotechnology
Health Diagnostics
Pharmaceutical
17 Dec 2012 Hsinchu, Taiwan Province, Taiwan
Crunchbase icon

Content report

The following text will be sent to our editors: